Alginate-loaded liposomes can protect encapsulated alkaline phosphatase functionality when exposed to gastric pH.

The present study has evaluated the potential of alginate-loaded liposomes as a vehicle for the oral delivery of bioactive proteins. The vesicles were prepared from the phospholipid dipalmatoyl phosphatidylcholine using a simple dry film hydration technique. Alkaline phosphatase (ALP) was used as a model bioactive protein, which was encapsulated in alginate-loaded liposomes and conventional liposomes. These vesicles were subject to physical characterization and stability analysis at varying pH values. The enzymatic activity of the ALP was evaluated following exposure to simulated gastric pH. The alginate-loaded liposomes were typically of the order of 10 microm; however, there was evidence of vesicle aggregation thought to be due to alginate present on the surface of the vesicles. The typical size of the aggregated vesicles was approximately 30 microm. The enzyme activity of APL following 2 h of exposure to simulated gastric pH was maintained at a significantly higher level when encapsulated in the alginate-loaded liposomes as compared to ALP loaded in conventional liposomes [80% as compared to 55% (p < 0.05), respectively].

[1]  P Michael Davidson,et al.  Size, stability, and entrapment efficiency of phospholipid nanocapsules containing polypeptide antimicrobials. , 2003, Journal of agricultural and food chemistry.

[2]  S. Antimisiaris,et al.  Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  T. Tanaka,et al.  Application of liposomes to the pharmaceutical modification of the distribution characteristics of drugs in the rat. , 1975, Chemical & pharmaceutical bulletin.

[4]  Mathias Winterhalter,et al.  Protein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayer. , 2002, BMC biotechnology.

[5]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[6]  G. Skjåk‐Braek,et al.  Alginate as immobilization matrix and stabilizing agent in a two-phase liquid system: application in lipase-catalysed reactions. , 1992, Enzyme and microbial technology.

[7]  G. Gregoriadis,et al.  Liposome-entrapped plasmid DNA: characterisation studies. , 2000, Biochimica et biophysica acta.

[8]  Bochu Wang,et al.  Factors affecting protein release from microcapsule prepared by liposome in alginate. , 2005, Colloids and surfaces. B, Biointerfaces.

[9]  N. Mishra,et al.  Gel core liposomes: An advanced carrier for improved vaccine delivery , 2009, Journal of microencapsulation.

[10]  Wei Zhang,et al.  Composite microparticle drug delivery systems based on chitosan, alginate and pectin with improved pH-sensitive drug release property. , 2009, Colloids and surfaces. B, Biointerfaces.

[11]  Shailesh Singh,et al.  Past, present, and future technologies for oral delivery of therapeutic proteins. , 2008, Journal of pharmaceutical sciences.

[12]  E. Bonucci,et al.  Biochemical and immunohistochemical evidence that in cartilage an alkaline phosphatase is a Ca2+-binding glycoprotein , 1986, The Journal of cell biology.

[13]  H. Maibach,et al.  Liposomes and Niosomes as Topical Drug Delivery Systems , 2005, Skin Pharmacology and Physiology.

[14]  M. Wheatley,et al.  Microencapsulated liposomes in controlled drug delivery: strategies to modulate drug release and eliminate the burst effect. , 2003, Journal of pharmaceutical sciences.

[15]  J. Weiss,et al.  Liposomal Nanocapsules in Food Science and Agriculture , 2005, Critical reviews in food science and nutrition.

[16]  B. Sarmento,et al.  Insulin-loaded alginate microspheres for oral delivery – Effect of polysaccharide reinforcement on physicochemical properties and release profile , 2007 .

[17]  T Nagai,et al.  Oral administration of recombinant human erythropoietin in liposomes in rats: influence of lipid composition and size of liposomes on bioavailability. , 1996, Journal of pharmaceutical sciences.

[18]  Wayne R. Gombotz,et al.  Calcium-alginate beads for the oral delivery of transforming growth factor-β1 (TGF-β1): stabilization of TGF-β1 by the addition of polyacrylic acid within acid-treated beads , 1994 .

[19]  K. Hirschhorn,et al.  Properties of placental alkaline phosphatase. I. Molecular size and electrical charge of the various electrophoretic components of the six common phenotypes , 1970, Biochemical Genetics.

[20]  A. Rudolph,et al.  Liposome-encapsulated alginate: controlled hydrogel particle formation and release. , 1995, Journal of microencapsulation.

[21]  A. Picon,et al.  Proteinases encapsulated in stimulated release liposomes for cheese ripening , 1997, Biotechnology Letters.

[22]  Bochu Wang,et al.  Preparation and characterization of liposomes-in-alginate (LIA) for protein delivery system. , 2006, Colloids and surfaces. B, Biointerfaces.

[23]  K. Draget,et al.  Alginic acid gels: the effect of alginate chemical composition and molecular weight , 1994 .

[24]  M. Gaitan,et al.  Liposome-templated supramolecular assembly of responsive alginate nanogels. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[25]  R. Langer,et al.  Lipid-alginate interactions render changes in phospholipid bilayer permeability. , 1991, Biochimica et biophysica acta.

[26]  B. Keller.  Liposomes in nutrition , 2001 .

[27]  A. Mohammed,et al.  Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability. , 2004, International journal of pharmaceutics.